NRNancy Yolanda Urbina Romo

Nancy Yolanda Urbina Romo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nancy Yolanda Urbina Romo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Salud ginecológica en personas transgénero: ética médica e inclusión

    by Karellys Nathaly Saltos-Bustamante, María Ilusión Solís-Sánchez, Nancy Urbina-Romo

    Objetivo: describir las necesidades de salud ginecológica de las personas transgénero, en particular el cribado de cáncer, la anticoncepción y la preservación de la fertilidad, desde una perspectiva ética e inclusiva. Método: revisión narrativa de literatura indexada en PubMed y SciELO; se seleccionaron 15 documentos: guías, revisiones, estudios cuantitativos y estudios cualitativos latinoamericanos. Resultados: la prevalencia de VIH en mujeres trans fue del 19,1 % a nivel mundial y del 22,6 % en tres ciudades de Colombia. En hombres trans, el 10,8 % de las citologías fue insatisfactoria, frente al 1,3 % en mujeres cisgénero, y el 61 % de quienes se embarazaron había usado testosterona. Los estudios en Brasil y Argentina describen falta de respeto al nombre social, demoras y escasez de especialistas. Conclusión: la atención ginecológica debe basarse en los órganos presentes, ofrecer anticoncepción y preservación de la fertilidad y eliminar las barreras discriminatorias.

  • Open Access

    Pacientes con COVID-19 grave en cuidados intensivos: revisión narrativa

    by María Ilusión Solís-Sánchez, José Luis Cerano-Fuentes, Nancy Yolanda Urbina-Romo, Andrés Gustavo Toscano-Ponce

    Objetivo: analizar las características clínicas, la mortalidad, los factores de riesgo y los tratamientos de los pacientes con COVID-19 grave ingresados en unidades de cuidados intensivos. Método: revisión narrativa de literatura indexada en PubMed y SciELO; se seleccionaron 15 documentos: cohortes, un metaanálisis y ensayos clínicos aleatorizados. Resultados: en Europa, cerca de tres cuartas partes de los pacientes críticos eran varones y la mitad tenía hipertensión. La mortalidad en cuidados intensivos descendió del 60 % al 36 % durante 2020, pero en América Latina alcanzó el 59 % en Brasil y el 47,8 % en Medellín. La edad, la diabetes, la obesidad y la hipoxemia grave aumentaron el riesgo de muerte. La dexametasona, el tocilizumab y la posición prona en pacientes despiertos mejoraron los desenlaces. Conclusión: el pronóstico depende de la gravedad al ingreso y de la aplicación de tratamientos con eficacia demostrada.

  • Open Access

    Comorbilidades y gravedad de la COVID-19 en pacientes hospitalizados: revisión narrativa

    by María Ilusión Solís-Sánchez, José Luis Cerano-Fuentes, Nancy Yolanda Urbina-Romo, Carlos Antonio Escobar-Suárez

    Objetivo: analizar la frecuencia de las comorbilidades en los pacientes hospitalizados por COVID-19 y su relación con la gravedad y la mortalidad. Método: revisión narrativa de literatura indexada en PubMed y SciELO; se seleccionaron 15 documentos: series de casos, cohortes nacionales, metaanálisis y ensayos clínicos aleatorizados. Resultados: la hipertensión, la diabetes y la obesidad fueron las comorbilidades más frecuentes en China, Estados Unidos, México y Perú. Tener una comorbilidad aumentó el riesgo de ingreso en cuidados intensivos, ventilación o muerte (HR 1,79), y tener dos o más, aún más (HR 2,59). La lesión renal aguda afectó al 36,6 % de los hospitalizados, y el buen control glucémico se asoció con menor mortalidad. La dexametasona redujo la mortalidad en quienes requerían oxígeno o ventilación. Conclusión: identificar las comorbilidades al ingreso permite estratificar el riesgo y vigilar las complicaciones renales y metabólicas.

  • Open Access

    Interpretation of Mayer-Rokitansky-Küster-Hauser syndrome by systematic literature review

    by Nancy Yolanda Urbina Romo, Nicole Ahily Serrano Escobar, María Ilusión Solís Sánchez

    Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, also known as Müllerian aplasia, is a rare congenital anomaly affecting the female genital tract, characterized by the absence of the uterus, cervix and upper vagina in women with normal appearance, karyotype 46 XX and normal endocrine function. The aim of the study was to interpret the main risk factors, clinical criteria and diagnosis of MRKH syndrome and its psychosocial impact through a literature review. A descriptive documentary literature review was conducted, analyzing articles published between 2019 and 2023 in high-impact journals. Sixteen articles were identified, including case studies and theoretical sources of information. The syndrome was found to affect approximately 1 in 4 000 to 5 000 women, with possible genetic basis. Two types are distinguished: type I, with absence of the uterus and vagina, and type II, with additional kidney and skeletal malformations. Diagnosis is made by ultrasound and MRI, and treatment includes the creation of a neovagina through surgical or non-surgical procedures. The syndrome carries a significant emotional and psychological burden due to infertility and sexual difficulties. It was concluded that MRKH involves risk factors such as family history, primary amenorrhea and normal development, requiring a multidisciplinary approach and including treatment options. In Ecuador, the lack of protocols and awareness presents challenges for those affected. It is vital to raise awareness of this condition and support research to improve the quality of life of those affected

  • Open Access

    Asherman syndrome: risk factors, clinical criteria and diagnosis in current literature

    by Nancy Yolanda Urbina Romo, Daniel Alejandro Sánchez Álvarez, Maria Ilusion Solís Sánchez

    Asherman's syndrome is a condition characterized by the presence of uterine adhesions or uterine synechiae that are caused by unintentional trauma, severe infections or endometrial hypoxia in a pregnant uterus. The aim of the study was to identify the main risk factors and diagnostic alternatives for Asherman's syndrome through literature review. In an effort to better understand Asherman's syndrome, a descriptive documentary study reviewed articles published from 2019 to 2023 in high-impact journals, selecting 17 for analysis. These included case studies and theoretical sources, highlighting the still unknown pathophysiology of the syndrome. It was confirmed that diagnosis is mainly based on hysterosalpingography and hysteroscopy, although these methods do not guarantee complete endometrial recovery, leading to high recurrence rates and low conception success rates. This underscores the need for complementary therapies to restore the uterine cavity and prevent new adhesions. In addition to the medical challenges, the study highlights the significant emotional and psychological impact of the syndrome, underscoring the importance of emotional and psychological support for those affected, as well as the need to raise awareness and support research to improve their quality of life. In conclusion, partial or total obstruction of the uterine cavity by adhesions is noted as a risk, emphasizing the need for a multidisciplinary approach to treatment. The study highlights the absence of clinical guidelines and awareness in Ecuador, which hinders the management of this condition El síndrome de Asherman es una condición que se caracteriza por la presencia de adherencias uterinas o sinequias uterinas que son causadas por traumas no intencionales, infecciones severas u hipoxia del endometrio en un útero gestante. El objetivo del estudio fue identificar los principales factores de riesgo y alternativas de diagnóstico del síndrome de Asherman mediante revisión bibliográfica. En un esfuerzo por comprender mejor el síndrome de Asherman, un estudio descriptivo documental revisó artículos publicados de 2019 a 2023 en revistas de alto impacto, seleccionando 17 para análisis. Estos incluyeron estudios de casos y fuentes teóricas, destacando la fisiopatología aún desconocida del síndrome. Se confirmó que el diagnóstico se basa principalmente en la histerosalpingografía e histeroscopia, aunque estos métodos no garantizan la recuperación completa del endometrio, lo que lleva a altas tasas de recurrencia y bajos índices de éxito en la concepción. Esto subraya la necesidad de terapias complementarias para restaurar la cavidad uterina y prevenir nuevas adherencias. Además de los retos médicos, el estudio resalta el significativo impacto emocional y psicológico del síndrome, subrayando la importancia del apoyo emocional y psicológico para los afectados, así como la necesidad de aumentar la conciencia y apoyar la investigación para mejorar su calidad de vida. Concluyentemente, se señala la obstrucción parcial o total de la cavidad uterina por adherencias como un riesgo, enfatizando la necesidad de un enfoque multidisciplinario para el tratamiento. El estudio destaca la ausencia de guías clínicas y sensibilización en Ecuador, lo que dificulta la gestión de esta condición

  • Open Access

    Analysis of the diagnosis and management of cervical ectopic pregnancies in Ecuador, through the study of cases described in the bibliography

    by Christian Xavier Mata Chango, Nancy Urbina Romo, María Ilusión Solís Sánchez

    Ectopic pregnancy is a condition in which the fertilized egg implants and begins to grow outside the uterus, usually in one of the fallopian tubes. Currently, with the advancement of science, the diagnosis can be made within the first weeks of evolution, after fertilization, identifying the gestational sac in the cervix using ultrasound techniques that seek to implement a measured treatment that does not affect the fertility of the the patient. The objective of the research consists of analysis of the diagnosis and management of cervical ectopic pregnancies in Ecuador, through the study of cases described in the bibliography. The type of research is of a descriptive bibliographic nature, because it seeks to identify the diagnostic tools and clinical criteria described, as well as risk factors described in the bibliography. There are clinical criteria that help detect a cervical ectopic pregnancy such as intense abdominal and pelvic pain, abundant vaginal bleeding, hemorrhages and sensitivity in the area near the cervix. Among the treatment options that exist are medications such as methotrexate or some others that inhibit embryonic growth. In Ecuador this problem is growing and is due to the absence of knowledge about the malformation and the lack of a protocol for its management and resolution, given that there is no established order in how to treat patients with this pathology, causing medical care slows down and generates greater complications

  • Open Access

    Analysis of the diagnosis and management of cervical ectopic pregnancies in Ecuador, through the study of cases described in the bibliography

    by Christian Xavier Mata Chango, Nancy Urbina Romo, María Ilusión Solís Sánchez

    Ectopic pregnancy is a condition in which the fertilized egg implants and begins to grow outside the uterus, usually in one of the fallopian tubes. Currently, with the advancement of science, the diagnosis can be made within the first weeks of evolution, after fertilization, identifying the gestational sac in the cervix using ultrasound techniques that seek to implement a measured treatment that does not affect the fertility of the the patient. The objective of the research consists of analysis of the diagnosis and management of cervical ectopic pregnancies in Ecuador, through the study of cases described in the bibliography. The type of research is of a descriptive bibliographic nature, because it seeks to identify the diagnostic tools and clinical criteria described, as well as risk factors described in the bibliography. There are clinical criteria that help detect a cervical ectopic pregnancy such as intense abdominal and pelvic pain, abundant vaginal bleeding, hemorrhages and sensitivity in the area near the cervix. Among the treatment options that exist are medications such as methotrexate or some others that inhibit embryonic growth. In Ecuador this problem is growing and is due to the absence of knowledge about the malformation and the lack of a protocol for its management and resolution, given that there is no established order in how to treat patients with this pathology, causing medical care slows down and generates greater complications